THURSDAY, Sept. 25, 2025 -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to...
Vous n'êtes pas connecté
WEDNESDAY, Aug. 27, 2025 -- A remotely delivered weight-loss intervention (WLI) induces significant weight loss in patients with breast cancer and overweight or obesity, according to a study published online Aug. 21 in JAMA Oncology. Jennifer A...
THURSDAY, Sept. 25, 2025 -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to...
THURSDAY, Sept. 25, 2025 -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to...
THURSDAY, Sept. 25, 2025 -- Remote perioperative telemonitoring (RPM) improves postoperative functional recovery and symptoms among patients...
THURSDAY, Sept. 25, 2025 -- Remote perioperative telemonitoring (RPM) improves postoperative functional recovery and symptoms among patients...
MONDAY, Sept. 22, 2025 -- Oral bacteria and fungi are associated with an increased risk for pancreatic cancer development, according to a study...
WEDNESDAY, Oct. 1, 2025 -- Women who do not participate in their first eligible mammogram screening have a long-term risk for dying from breast...
TUESDAY, Sept. 23, 2025 -- In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs)...
TUESDAY, Sept. 23, 2025 -- In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs)...
THURSDAY, Sept. 25, 2025 -- For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast...
THURSDAY, Sept. 25, 2025 -- For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast...